HUMAN VAGINAL PATHOGEN INHIBITION STUDIES ON AQUEOUS, METHANOLIC AND SAPONINS EXTRACTS OF STEM BARKS OF ZIZIPHUS MAURITIANA
HTML Full TextHUMAN VAGINAL PATHOGEN INHIBITION STUDIES ON AQUEOUS, METHANOLIC AND SAPONINS EXTRACTS OF STEM BARKS OF ZIZIPHUS MAURITIANA
Raghvendra Dubey*1, Kushagra Dubey 2, C. Sridhar 3 and K. N. Jayaveera 4
Chordia Institute of Pharmacy 1, Indore, Madhya Pradesh, India
Ujjain Institute of Pharmaceutical Sciences 2, Ujjian, Madhya Pradesh, India
CES College of Phamacy 3, Kurnool, Andhra Pradesh, India
Director, Oil Technology & Research Institute 4, Anantapur, Andhra Pradesh, India
ABSTRACT
The aqueous, methanolic and saponin extracts of Zizyphus mauritiana barks has been screened for antimicrobial activities against some human vaginal pathogens Staphylococcus aureus, Pseudomonas aeruginosa, streptococcus facecalis, klebsiella pneumoniae, Escherichia coli, Enterobacter faecalis, Enterobacter faecium and Proteus mirabilis isolated from patient samples. Extracts were found to produce significant inhibition against all the pathogens. Saponin extract were observed to be more active than methanolic and aqueous fraction. Extracts are found to be more active against Staphylococcus aureus and Escherichia coli strains.
Keywords:
Ziziphus Species, Human Vaginal Pathogens, |
Saponin
INTRODUCTION: From ancient times, different parts of medicinal plants have been used to cure specific ailments. Natural antimicrobials can be derived from plants, animal tissues, or microorganisms. The shortcomings of the drugs available today, propel the discovery of new pharmacotherapeutic agents in medicinal plants 1-3.
Ziziphus belongs to the kingdom plantae, order- roasles, division- magnoliophyta, class- magnoliopsida, family- rhamnaceae, and genus- ziziphus. Z. mauritiana is a fast growing small to medium-sized, single or multi-stemmed, spiny shrub or tree, which is almost evergreen, but is deciduous during the dry season. It can reach up to 12 m tall and 30 cm diameter at breast height, but is highly variable in size and general appearance. The bark is dark grey, dull black or reddish with long vertical fissures, reddish and fibrous inside. The branches are spreading and droop at the ends. Stipules are mostly spines, in pairs with one hooked and one straight, or both hooked 4-10.
Urinary tract infections (UTIs) are a leading cause of morbidity and health care expenditures in persons of all ages. Sexually active young women are disproportionately affected, but several other populations, including elderly persons and those undergoing genitourinary instrumentation or catheterization, are also at risk.. A urinary tract infection (UTIs) describes a condition in which there are micro organisms established and multiplying within the urinary tract. It is most often due to bacteria (95%), but may also include fungal and viral infection 11-14.
In the present study methanolic, aqueous and saponin Extracts of Barks of ziziphus nummmlaria plants were screened for potential antibacterial activity toward vaginal pathogens causing urinary tract infections (UTIs).
MATERIALS AND METHODS:
Plant materials: Barks of Ziziphus mauritiana were collected from Malwa region of Madhya Pradesh in the month of Feb-March, 2007 and were identified by the Botany Department, Janata PG College, A.P.S. University, Rewa (M.P.). The bark were later air-dried, powdered and stored in an air-tight container for further use.
Preparation of extracts 9-10: Sample were shattered and screened with 40 mesh. It was soxhlet extracted three times with petroleum benzene for 4hr at 60oC. After drying and levigation, the residues were inverse flow extracted 10 times with 70% methanol for 4hr at 85oC, then were filtrated and the residue was extracted with distilled water for 48hr under reflux condition. The alcohol solution (Filtrate) was evaporated to dryness with reduced pressure at 60oC, and dissolved with water. After filtration and discarding the extraneous components, the solution was extracted by adding water-saturated n-butanol (1:1 v/v), the n-butanol phase was then treated by 1M KOH, alkaline–water phase was removed. The n-butanol phase evaporated to dryness under pressure and the raw saponin was obtained. All extracts were screened for phytochemical analysis.
Preparation of microorganisms for experiment: All the microorganisms were isolated from in & outpatients samples from Chotiram hospital and research centre Indore. For use in experiments, the organisms were sub-cultured in nutrient broth, nutrient agar, Macconky agar and Blood agar media. Muller Hinton agar was used in antibiotic sensitivity testing.
Preparation and application of disks for experiment 15-24: Different concentration of the extracts (10-60µg/ml) was prepared by reconstituting with DMSO. The test microorganisms were streak to Muller Hinton agar medium by streaking plate method. After streaking the autoclaved filter paper discs (5 mm in diameter) impregnated with the extracts were placed on plates using flame-sterilized forceps. The antibacterial assay plates were incubated at 37°C for 24hr. For positive control Amoxycillin/ cefitaxime/Ampicillin (60µg/ml) and for negative control solvent DMSO was used.
Observation of results: Results were recorded as presence or absence of zone of inhibition. The inhibitory zone around test paper disks indicated absence of bacterial growth and it was reported as positive (growth inhibition observed) and absence of zone as negative. The test was repeated thrice in interday interval to insure reliability of the results. The diameters of the inhibition zones were measured in mm (after subtraction the diameter of disc i.e. 5mm), shown in table 1. The concentration of extract showing inhibition was further diluted and experiment was repeated to identify the minimum inhibitory concentration (MIC), shown in table 2. The Percentage of relative inhibition zone diameter (% RIZD) as compare to inhibition obtained from standard drug at same concentration was calculated, shown in table 3.
TABLE 1: ZONE OF INHIBITION FOR EXTRACTS, STANDARD & CONTROL
Con in
µg/ml |
Zone of Inhibition (mm)* | ||||||||
EC | PA | EFa | EFi | KP | SF | SA | PM | ||
ME | 10 | - | - | - | - | - | - | - | - |
20 | - | - | - | - | - | - | 2.33±0.16 | - | |
40 | 7.66±0.16 | 6.66±0.16 | 4.16±0.16 | 5.33±0.16 | - | 5.0±0.28 | 8.66±0.16 | 2.33±0.33 | |
60 | 10.33±0.16 | 10.66±0.16 | 7.33±0.16 | 8.16±0.16 | 8.5±0.288 | 8.33±0.16 | 13.0±0.28 | 4.66±0.16 | |
AE | 10 | - | - | - | - | - | - | - | - |
20 | - | - | - | - | - | - | 2.16±0.16 | - | |
40 | 5.16±0.16 | 5.83±0.16 | 4.16±0.16 | 3.83±0.16 | - | 4.83±0.16 | 8.33±0.16 | 2.16±0.16 | |
60 | 8.0±0.28 | 9.5±0.288 | 6.83±0.16 | 6.16±0.16 | 6.33±0.16 | 8.16±0.16 | 11.66±0.16 | 4.16±0.16 | |
SE | 10 | - | - | - | - | - | - | - | - |
20 | - | - | - | - | - | - | 2.83±0.16 | - | |
40 | 7.83±0.166 | 8.0±0.288 | 5.5±0.288 | 7.0±0.288 | 6.33±0.16 | 9.16±0.16 | 3.0±0.28 | ||
60 | 11.66±0.16 | 11.83±0.16 | 9.16±0.16 | 10.33±0.16 | 10.16±0.16 | 10.66±0.16 | 13.83±0.33 | 6.16±0.16 | |
SD | 60 | 22.5±0.763
(a) |
24.16±0.726
(a) |
19.5±0.28
(b) |
21.16±0.60
(a) |
24.83±0.60
(b) |
23.83±0.16
(a) |
25.16±0.726
(b) |
19.0±0.288
(a) |
Con | - | - | - | - | - | - | - | - | - |
* mm= Mean of three replicates±SEM; Met: Methanolic extract AE: Aqueous Extract SE: Saponin Extract Con: Control (DMSO) SD: Standard (a = cefitaxime, b= Amoxycillin); EC= Escherichia coli, PA= Pseudomonas aeruginosa, EFa= Enterobacter faecalis, EFi= Enterobacter faecium, KP= klebsiella pneumoniae, SF= Streptococcus facecalis, SA= Staphylococcus aureus and PM= Proteus mirabilis
TABLE 2 MINIMUM INHIBITORY CONCENTRATIONS (MIC) FOR EXTRACTS
Organism | Zone of inhibition and Minimum Inhibitory Concentration (MIC) for extracts | |||||||
EC | PA | EFa | EFi | KP | SF | SA | PM | |
ME | 2.33±0.33
(26µg/ml) |
2.66±0.16
(36µg/ml) |
2.5±0.288
(38µg/ml) |
2.33±0.33
(36µg/ml) |
2.16±0.16
(46 µg/ml) |
2.16±0.16
(38µg/ml) |
2..33±0.16
(20µg/ml) |
2.33±0.33
(40µg/ml) |
AE | 2.16±0.16
(28µg/ml) |
2.16±0.16
(36µg/ml) |
2.33±0.16
(38µg/ml) |
2.16±0.16
(38µg/ml) |
2.33±0.16
(50µg/ml) |
2.16±0.16
(38µg/ml) |
2.16±0.16
(20µg/ml) |
2.16±0.16
(40µg/ml) |
SE | 2.33±0.16
(26µg/ml) |
3.16±0.16
(36µg/ml) |
2.83±0.16
(38µg/ml) |
2.33±0.16
(34µg/ml) |
2.33±0.33
(46µg/ml) |
2.5±0.28
(34µg/ml) |
2.83±0.16
(20µg/ml) |
3.0±0.288
(40µg/ml) |
Met: Methanolic extract AE: Aqueous Extract SE: Saponin Extract; EC= Escherichia coli, PA= Pseudomonas aeruginosa, EFa= Enterobacter faecalis, EFi= Enterobacter faecium, KP= klebsiella pneumoniae, SF= Streptococcus facecalis, SA= Staphylococcus aureus and PM= Proteus mirabilis
TABLE 3: PERCENTAGE OF RELATIVE INHIBITION ZONE DIAMETER (% RIZD) FOR EXTRACTS AS COMPARE TO STANDARD AT 60µg/ml
Organism | Percentage of relative Inhibition Zone diameter (% RIZD) at 60µg/ml | |||||||
EC | PA | EFa | EFi | KP | SF | SA | PM | |
ME | 45.91% | 44.12% | 37.55% | 33.08% | 34.23% | 34.95% | 51.66% | 24.52% |
AE | 35.55% | 39.32% | 35.02% | 29.11% | 25.49% | 34.24% | 46.34% | 21.89% |
SE | 51.82% | 48.96% | 46.97% | 48.81% | 40.91% | 44.73% | 54.96% | 34.36% |
Met: Methanolic extract AE: Aqueous Extract SE: Saponin Extract; EC= Escherichia coli, PA= Pseudomonas aeruginosa, EFa= Enterobacter faecalis, EFi= Enterobacter faecium, KP= klebsiella pneumoniae, SF= Streptococcus facecalis, SA= Staphylococcus aureus and PM= Proteus mirabilis
RESULTS AND DISCUSSION: In this study the results of the investigations show that all the extracts from the bark possess antimicrobial activities against mentioned test organisms. The minimum inhibitory concentration lies in the range from 20µg/ml to 50µg/ml.
Saponin extract were observe to be more active than ethanol and aqueous extracts. As compare to the standard, extracts were observed to be less active at concentration 60µg/ml. The percentage of relative inhibition zone diameter (% RIZD) observed to be in the range 21.89%-54.96% shown in table 3. Results clearly indicate that further purification of this compounds can leads to isolation of potent antibacterial compound active against some urinary pathogens.
ACKNOWLEDGMENT: Sincerely thanks to Dr. S.N. Dwivedi, Principal Investigator, Department of Botany, Janata College, APS University (M.P.), Dr. Chitins, Head, Department of Microbiology, Choitram Hospital & Research Centre, Indore. Dr. (Mrs.) V. Kothari, Head, Pathology Department, CHL Apollo, Indore for their valuable support.
REFERENCES:
- Stuffness M and Douros J: Current status of the NCI plant and animal product program. J Nat Prod 1982; 45:1-14.
- Baker JT, Borris RP and Carte B: Natural product drug discovery and development: New perspective on international collaboration. J Nat Prod 1995; 58: 1325-1357.
- Farombi EO: African indigenous plants with chemotherapeutic potentials and biotechnological approach to the production of bioactive prophylactic agents. African J Biotech 2003; 2: 662-671.
- Liu MJ and Cheng CY: A taxonomic study of the genus Ziziphus. Acta Hortic. 1995; 390: 161-165.
- Bhansali AK: Monographic Study of the family Rhamnaceae of India. Ph.D. thesis, University of Jodhpur, India, 1975
- Singh JP and Singh, IS: Some promising varieties of ber. Indian Hortic. 1973; 18(2): 3-28.
- Jawanda JS, Bal JS, Josan JS and Mann SS: Ber cultivation in Punjab. Punjab Hortic. Journal 1981; 21: 17-22.
- Srivastava SK and Srivastava SD: Structure of Zizogenin, a new sapogenin from Ziziphus mauritiana. Phytochemistry 1979; 18(10): 1758-1759.
- Huang RL, Wang W-Y, Kuob Y-H and Lina Y-L: Cytotoxic Triterpenes from the Fruit of Ziziphus jujube, The Chinese Pharmaceutical Journal 2001; 53: 179-184.
- Jiang J-G, Huang X-J, Chen J and Lin Q-S: Comparison of the sedative and hypnotic effect of flavanoids, saponins and polysaccharides extracted from semen Ziziphus jujube. Natural Product Research 2007; 21(4): 310-320.
- Kunin CM: Urinary tract infections in females. Clin Infect Dis 1994; 18: 1-12.
- Patton JP, Nash DB and Abrutyn E: Urinary tract infection: economic considerations. Med Clin North Am 1991; 75: 495-513.
- Stamm WE and Hooton TM: Management of urinary tract infections in adults. N Engl J Med 1993; 329: 1328-34.
- Sobel JD: Pathogenesis of urinary tract infection. Role of host defenses. Infect Dis Clin North Am 1997; 11: 531-49.
- Binutu OA and Lajubutu B: Antimicrobial potentials of some plant species of the Bignoniaceae family. Afr J Med Med Sci 1994; 23: 269.
- Oyedeji OA, Adeniyi BA, Ajayi O and Konig WA: Essential oil composition of Piper guineense and its antimicrobial activity. Another Chemotype from Nigeria. Phytother Res 2005; 19: 362-364.
- Alade PI and Irobi ON: Antimicrobial activities of crude leaf extracts of Acalypha wilkensiana. J Ethnopharmacol 1993; 39: 171-174.
- Rabe T and Van J: Antibacterial activity of South African plants used for medicinal purposes. J Ethnopharmacol 1997; 56: 81-87.
- Perez C, Pauli M and Bazevque P: An antibiotic assay by the agar well diffusion method. Acta Biol Med Exp 1990; 15: 113-115.
- Fleischer TC, Ameade EPK, Mensah MLK and Sawer IK: Antimicrobial activity of the leaves and seeds of Bixa orellana. Fitoterapia 2003; 74: 136-38.
- Taylor RSL, Manandhar NP, Hudson JB and Towers GHN: Screening of selected medicinal plants of Nepal for antimicrobial activities. J. Ethnopharmacol. 1995; 546: 153-159.
- Samy RP: Antimicrobial activity of some medicinal plants from India. Fitoterpia 2005; 76: 697-699.
- Alzoreky NS and Nakahara K: Antibacterial activity of extracts from some edible plants commonly consumed in Asia. International Journal of Food Microbiology 2003; 80: 223–30.Bauer AW, Kirby WMM, Sherris JC and Turck M: Antibiotic susceptibility testing by standardized single disc method. American Journal of Clinical Pathology 1966; 36: 493–6.
Article Information
22
659-663
385
1475
English
Ijpsr
Raghvendra Dubey*, Kushagra Dubey , C. Sridhar and K. N. Jayaveera
A12/16, Basant Vihar colony, Ujjain, Madhya Pradesh, India
09 November, 2010
28 January, 2011
17 February, 2011
http://dx.doi.org/10.13040/IJPSR.0975-8232.2(3).659-63
01 March, 2011